Filing Details
- Accession Number:
- 0001567619-21-014772
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-09 17:02:41
- Reporting Period:
- 2021-08-06
- Accepted Time:
- 2021-08-09 17:02:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1094176 | Anne M Szostak | One Idexx Drive Westbrook ME 04092 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-08-06 | 312 | $681.49 | 9,905 | No | 4 | S | Indirect | 2021 Szostak IDEXX GRAT |
| Common Stock | Disposition | 2021-08-06 | 368 | $682.77 | 9,537 | No | 4 | S | Indirect | 2021 Szostak IDEXX GRAT |
| Common Stock | Disposition | 2021-08-06 | 120 | $683.71 | 9,417 | No | 4 | S | Indirect | 2021 Szostak IDEXX GRAT |
| Common Stock | Disposition | 2021-08-06 | 439 | $684.96 | 8,978 | No | 4 | S | Indirect | 2021 Szostak IDEXX GRAT |
| Common Stock | Disposition | 2021-08-06 | 261 | $685.98 | 8,717 | No | 4 | S | Indirect | 2021 Szostak IDEXX GRAT |
| Common Stock | Disposition | 2021-08-06 | 300 | $689.60 | 8,417 | No | 4 | S | Indirect | 2021 Szostak IDEXX GRAT |
| Common Stock | Disposition | 2021-08-06 | 300 | $690.65 | 8,117 | No | 4 | S | Indirect | 2021 Szostak IDEXX GRAT |
| Common Stock | Disposition | 2021-08-06 | 300 | $691.75 | 7,817 | No | 4 | S | Indirect | 2021 Szostak IDEXX GRAT |
| Common Stock | Disposition | 2021-08-06 | 595 | $693.91 | 7,222 | No | 4 | S | Indirect | 2021 Szostak IDEXX GRAT |
| Common Stock | Disposition | 2021-08-06 | 5 | $694.62 | 7,217 | No | 4 | S | Indirect | 2021 Szostak IDEXX GRAT |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | 2021 Szostak IDEXX GRAT |
| No | 4 | S | Indirect | 2021 Szostak IDEXX GRAT |
| No | 4 | S | Indirect | 2021 Szostak IDEXX GRAT |
| No | 4 | S | Indirect | 2021 Szostak IDEXX GRAT |
| No | 4 | S | Indirect | 2021 Szostak IDEXX GRAT |
| No | 4 | S | Indirect | 2021 Szostak IDEXX GRAT |
| No | 4 | S | Indirect | 2021 Szostak IDEXX GRAT |
| No | 4 | S | Indirect | 2021 Szostak IDEXX GRAT |
| No | 4 | S | Indirect | 2021 Szostak IDEXX GRAT |
| No | 4 | S | Indirect | 2021 Szostak IDEXX GRAT |
Footnotes
- The reporting person is the settlor and trustee of the 2021 Szostak IDEXX GRAT (the "GRAT"). The GRAT is irrevocable, and the reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.
- Represents the weighted average price of the shares sold ranging from a low of $681.18 to a high of $682.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $682.30 to a high of $683.20 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $683.38 to a high of $683.79 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $684.39 to a high of $685.25 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $685.48 to a high of $686.35 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $689.27 to a high of $690.23 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $690.32 to a high of $691.21 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $691.47 to a high of $692.22 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $693.53 to a high of $694.51 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
